Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Dermatology · Clin Exp Dermatol · 2026-10-27
Meta-analysisn = 5 trials
Advani et al. Efficacy and safety of icotrokinra for plaque psoriasis: a systematic review and meta-analysisDermatology · Br J Dermatol · 2026-09-18
RCTn = 1,505
Stein Gold et al. Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trialsDermatology · Br J Dermatol · 2026-09-18
RCTn = 453
Blauvelt et al. Repeated switching between biosimilar ABP 654 and reference ustekinumab in patients with moderate-to-severe plaque psoriasis: a randomized double-blinded clinical trial to support interchangeabilityDermatology · JAMA Dermatol · 2026-09-01
Meta-analysisn = 15,005
Liu et al. Tuberculosis-Related Outcomes in Dermatologic Patients Receiving Systemic Therapy: A Systematic Review and Meta-AnalysisDermatology · JAMA Dermatol · 2026-07-01
RCTn = 274
Lebwohl et al. Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical TrialDermatology · JAMA Dermatol · 2026-07-01
RCTn = 111
Smith et al. Text Messaging for Cardiovascular Risk Prevention in Psoriasis: A Randomized Clinical TrialDermatology · J Eur Acad Dermatol Venereol · 2026-06-02
Meta-analysisn = 18 studies
Yang et al. Biologic therapies and psoriatic arthritis risk in psoriasis: A systematic review and meta-analysisDermatology · J Eur Acad Dermatol Venereol · 2026-05-23
RCTn = 311
Warren et al. Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findingsDermatology · J Eur Acad Dermatol Venereol · 2026-05-15
Meta-analysisn = 10,266
Lai et al. Systematic review and network meta-analysis of biologics and small molecules for scalp psoriasisDermatology · J Eur Acad Dermatol Venereol · 2026-04-28
Meta-analysisn = 975 samples
Torres-Moral et al. Transcriptomic meta-analysis identifies core molecular pathways in plaque psoriasisDermatology · J Eur Acad Dermatol Venereol · 2026-04-17
Meta-analysisn = 13,902
Mao et al. Predictors of clinical response to biologics in psoriasis: A systematic review and meta-analysisDermatology · Acta Derm Venereol · 2026-04-16
RCTn = 281
Ding et al. Efficacy and Safety of Xeligekimab Compared to Other IL-17A Inhibitors for Chinese Patients with Moderate-to-severe Plaque Psoriasis: A Matching-adjusted Indirect ComparisonsDermatology · J Am Acad Dermatol · 2026-04-03
RCT
Gao et al. A multicenter, randomized, double-blinded, placebo-controlled phase III trial to evaluate efficacy and safety of picankibart in moderate-to-severe plaque psoriasisDermatology · JAMA Dermatol · 2026-04-01
Secondary analysisn = 743
Augustin et al. Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label ExtensionDermatology · J Am Acad Dermatol · 2026-03-23
RCTn = 77
Iversen et al. Impact of early treatment of psoriasis on disease recurrence-Results from the STEPIn studyDermatology · J Eur Acad Dermatol Venereol · 2026-02-12
RCTn = 133 patients
Cai et al. Bimekizumab efficacy and safety in Chinese patients with psoriasis in the BE SHINING Phase 3 studyDermatology · J Eur Acad Dermatol Venereol · 2026-02-11
RCTn = 38
Nassr et al. Phase 1 study of balinatunfib, an oral inhibitor of TNFR1 signal in mild-to-moderate psoriasisDermatology · J Eur Acad Dermatol Venereol · 2025-12-30
Guideline
Masson Regnault et al. French guidelines on systemic treatments for moderate-to-severe psoriasis in adults: Update 2025Dermatology · J Eur Acad Dermatol Venereol · 2025-12-19
Meta-analysisn = 1,145
Morrow et al. Impact of weight-loss interventions on psoriasis severity: A systematic review and meta-analysisDermatology · J Eur Acad Dermatol Venereol · 2025-12-10
RCTn = 289 patients
Merola et al. Results from the 32-week, phase 3 DISCREET study of apremilast in patients with moderate to severe genital psoriasis